Virginia Pérez‐Grijalba
Virginia Pérez‐Grijalba publishes mostly in Physiology, Psychiatry and Mental health and Molecular Biology, on topics such as Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research and Cholinesterase and Neurodegenerative Diseases.
- World rank
- #1,874,012 of 7,710,434 ranked researchers
- Rank in Spain
- #39,946 of 204,306
- Works
- 36
- Citations
- 1.2k
- Citations per work
- 34.4
What does Virginia Pérez‐Grijalba research?
Virginia Pérez‐Grijalba's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (11%), Computer Science (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2261.6%
- Medicine2261.6%
- Everything else924.1%
- Life Sciences411.0%
- Physical Sciences13.3%
- Computer Science13.3%
- 1Physiology31% of their works
- 2Psychiatry and Mental health23% of their works
- 3Molecular Biology11% of their works
- 4Pharmacology4% of their works
- 5Computational Theory and Mathematics3% of their works
- 6Cardiology and Cardiovascular Medicine3% of their works
Research topics
- Alzheimer's disease research and treatments
- Dementia and Cognitive Impairment Research
- Cholinesterase and Neurodegenerative Diseases
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Computational Drug Discovery Methods
- Epilepsy research and treatment
- Machine Learning in Bioinformatics
- Cancer-related cognitive impairment studies
Which keywords describe Virginia Pérez‐Grijalba's research?
The keywords of their largest research topics: Amyloid Hypothesis, Tau Pathology, Alzheimer's Disease, Dementia, Mild Cognitive Impairment, Machine Learning, Acetylcholinesterase and Cholinesterase Inhibitors.
- Subcellular Localization
- Cognitive Function
- Virtual Screening
- Seizures
- Epilepsy
- Cholinesterase Inhibitors
- Machine Learning
- Dementia
- Tau Pathology
- Amyloid Hypothesis
- Alzheimer's Disease
- Mild Cognitive Impairment
- Acetylcholinesterase
- Cardiac Amyloidosis
- Molecular Docking
- Transthyretin
- Chemotherapy
- Protein
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Amyloid Hypothesis261 topic
- Tau Pathology261 topic
- Alzheimer's Disease212 topics
- Dementia171 topic
- Mild Cognitive Impairment171 topic
- Machine Learning52 topics
- Acetylcholinesterase41 topic
- Cholinesterase Inhibitors41 topic
- Cardiac Amyloidosis31 topic
- Epilepsy31 topic
- Molecular Docking31 topic
- Seizures31 topic
- Transthyretin31 topic
- Virtual Screening31 topic
- Chemotherapy21 topic
- Cognitive Function21 topic
- Protein21 topic
- Subcellular Localization21 topic
Where does Virginia Pérez‐Grijalba work?
Virginia Pérez‐Grijalba's main affiliation in the publication record is Fundació ACE, Spain.
How many publications and citations does Virginia Pérez‐Grijalba have?
OpenAlex counts 36 works and 1,239 citations for Virginia Pérez‐Grijalba, an h-index of 17, ranking #1,874,012 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Virginia Pérez‐Grijalba. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.